On a deeper level, the ability to study sleep and wakefulness objectively with polysomnography (PSG) provided biological psychiatry with one of its first and most accessible tools in the 1970s and 1980s. Hundreds of articles examined sleep in psychiatric disorders, especially depression, with the hope of providing improved measures for diagnosis, prognosis, and pathophysiology. These studies ultimately stalled with the recognition that PSG's summary measures provide a fairly blunt probe of the complex neural systems underlying sleep-wakefulness and mood regulation. By contrast, the basic neuroscience of sleep and wakefulness has exploded during the past 10 to 15 years, resulting in a detailed understanding of genetic, molecular, and neural mechanisms. Moreover, the development of affective and cognitive neuroscience has led to a resurgence of interest in the connections between sleep, mood, and cognition. Animal and human experiments now routinely combine self-reports and PSG recordings with functional imaging, electrophysiolgical, and genetic methods, and have begun to elucidate the common neural substrates that underlie sleep and psychiatric symptoms.
The authors of the 2 In Review articles 1,2 in this issue of The Canadian Journal of Psychiatry admirably address the multifaceted relations between sleep and psychiatric disorders. Dr Elliot Kyung Lee and Dr Alan B Douglass 1 provide a scholarly overview of sleep in each of the major psychiatric disorders, including findings from the first era of psychiatric sleep research, more recent neurobiological theories and findings, and a review of treatment approaches. This review illustrates the nonspecificity of summary PSG measures in psychiatric disorders, but also the complex neurochemistry underlying sleep measures. The sections on medication effects on sleep will be particularly useful to clinicians, and the detailed reference list provides the background for further study. Dr Lauren D Sculthorpe and Dr Douglass 2 focus more specifically on sleep and depression. They succinctly summarize major theories of sleep and depression, first proposed more than 30 years ago, but update these with recent neurobiological and clinical neuroscience findings. Thus clinicians can get a rapid overview of where the field has been and where it is going.
For instance, although they demonstrate the apparent nonspecificity of symptom complexes such as insomnia, and of PSG findings such as reduced slow-wave sleep, these articles also raise the possibility of common mechanisms across psychiatric disorders. In the same way that obsessivecompulsive or depressive symptom complexes are now recognized as the result of dysfunction in distinct neural circuits, increasing evidence suggests a distinct neural circuitry of insomnia. This dysfunction may be seen in conjunction with-or more provocatively, may precede and increase the risk for-the other types of abnormal circuits. In a similar way, the corticotropin releasing hormone abnormalities that have been demonstrated in at least a subset of insomnia patients may represent a vulnerability factor for later depression. Exciting new studies on the genetic regulation of circadian rhythms and sleep have identified mutations and polymorphisms associated with circadian period, circadian phase, sleep length, and sleep structure. More surprisingly, variations in these genes are also associated with dysregulation in other functions as diverse as longevity, metabolic regulation, cognitive function-and psychiatric symptoms. Finally, cognitive and affective neuroscience methods are increasingly used to examine the consequences of sleep and its disruptions, leading to the conclusion that learning, cognition, and mood regulation are among the major functions served by sleep.
For many of us, the 2 articles on sleep in this issue will provide a nostalgic revisit of an earlier era in biological psychiatry. More importantly, however, they also offer a reconceptualization that will lead to better patient care and a deeper understanding of the brain mechanisms underlying sleep and psychiatric disorders.
